Fee petition mechanics · Updated July 2026
California Cannabis Employment Discrimination Act attorney fee petition mechanics: date of adverse employment action based on off-duty cannabis use as primary Welch anchor, Gov. Code § 12954 attorney fees — FEHA § 12965 strong-plaintiff-presumption framework; pure Ketchum no Dague; AB 2188 effective January 1, 2024; no federal off-duty cannabis employment protection
California Cannabis Employment Discrimination Act enforcement (Gov. Code § 12954 — AB 2188 [Asm. Quirk-Silva, 2022], effective January 1, 2024; § 12954(a): it shall be unlawful for an employer to discriminate against a person in hiring, termination, or any term or condition of employment, or otherwise penalize a person if the discrimination is based upon: (1) the person's use of cannabis off the job and away from the workplace; or (2) an employer-required drug screening test that has found the person to have nonpsychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids; § 12954(b): exemptions apply to positions in the building and construction trades, positions requiring federal background investigation or security clearance, positions subject to DOT 49 C.F.R. Part 40 drug testing requirements, positions requiring a commercial driver's license, and positions under federal contractors subject to the Drug-Free Workplace Act; § 12954(c)(2): nothing in this section prohibits an employer from maintaining a workplace free of cannabis use or from disciplining an employee who is impaired by cannabis at the workplace or during work hours; § 12954 added as a FEHA provision — fee recovery through Gov. Code § 12965(b) FEHA framework: strong-plaintiff-presumption attorney fees; the ONLY statute in the fee-petition-mechanics series where the primary Welch anchor is simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES — the EMPLOYER'S OWN HRIS CALENDAR AND the DRUG TESTING LABORATORY'S OWN LIMS CALENDAR — because the adverse action (in the employer's HRIS) is directly caused by a drug test result (in the laboratory's LIMS) that is itself the basis for the § 12954 violation; the DATE OF ADVERSE EMPLOYMENT ACTION BASED ON OFF-DUTY CANNABIS USE OR NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT is the primary Welch anchor — simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES: (1) EMPLOYER'S OWN HRIS AND PAYROLL SYSTEM CALENDAR [Workday Human Capital Management, ADP Workforce Now, UKG Pro (formerly Kronos Workforce Ready), UKG Ready, SAP SuccessFactors HCM, BambooHR, Paylocity, Ceridian Dayforce — adverse action effective date (hiring rejection, termination effective date, demotion effective date) on employer's institutional HRIS and payroll calendar entirely outside plaintiff attorney's scheduling control] AND (2) DRUG TESTING LABORATORY'S OWN LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) CALENDAR [Quest Diagnostics Clinical Trials LIMS, LabCorp eScreen LIMS, Concentra occupational health LIMS, Accurate Background drug screening platform, National Health Laboratories occupational health platform — specimen collection date on collection site calendar, specimen accession date, immunoassay ELISA/EMIT screening date, GC-MS/MS confirmatory testing date, Medical Review Officer (MRO) review and verification date, electronic result transmission date to employer HR or MRO-to-employer reporting system — all on the drug testing laboratory's own institutional LIMS calendar entirely outside plaintiff attorney's scheduling control]; the KEY TECHNICAL DISTINCTION under § 12954: the GC-MS/MS confirmation test distinguishes non-psychoactive THC-COOH metabolites (which persist in urine for up to 30+ days and indicate only past off-duty use) from psychoactive THC (which indicates recent use and potential current impairment) — an employer who bases an adverse action on non-psychoactive THC-COOH metabolites in a confirmatory GC-MS/MS test is discriminating based on past off-duty cannabis use in violation of § 12954; an employer who bases adverse action on evidence of current impairment (behavioral observation, THC presence in blood indicating recent use) does not violate § 12954; no federal employment law protects off-duty cannabis use — cannabis remains Schedule I under the Controlled Substances Act (21 U.S.C. § 812(b)(1)); ADA 42 U.S.C. § 12114(a) explicitly excludes current illegal drug users from ADA protection → pure Ketchum no Dague; DISTINCT from FEHA § 12940(a) disability discrimination [§ 12940(a) prohibits discrimination based on disability status, including substance use disorder as a qualifying disability under Gonzales v. Raich; § 12954 prohibits discrimination based on off-duty cannabis use regardless of whether the use constitutes a disability — no disability diagnosis or reasonable accommodation request required under § 12954]; FEHA § 12940(m) reasonable accommodation [§ 12940(m) may require accommodation of cannabis use for medical purposes when medically supervised; § 12954 prohibits discrimination based on any off-duty cannabis use without need to establish medical purpose, physician recommendation, or disability diagnosis]; Ketchum v. Moses 24 Cal.4th 1122 (2001); PLCM Group Inc. v. Drexler 22 Cal.4th 1084 (2000); Hensley v. Eckerhart 461 U.S. 424 (1983) lodestar from DATE OF ADVERSE EMPLOYMENT ACTION BASED ON NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT; Missouri v. Jenkins 491 U.S. 274 (1989) fees-on-fees) — solos billing hourly on attorney fee recovery — in actions where the primary Welch temporal anchor is the DATE OF ADVERSE EMPLOYMENT ACTION BASED ON OFF-DUTY CANNABIS USE OR NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT (simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES: employer's HRIS calendar [Workday/ADP/UKG/SAP SuccessFactors/BambooHR/Paylocity/Ceridian Dayforce — adverse action effective date] + drug testing laboratory's LIMS calendar [Quest Diagnostics/LabCorp/Concentra/Accurate Background/National Health Labs — specimen collection date, immunoassay screen date, GC-MS/MS confirmation date, MRO review date, result transmission date] — all entirely outside plaintiff attorney's scheduling control; FEHA § 12965(b) strong-plaintiff-presumption attorney fees; AB 2188 effective January 1, 2024; pure Ketchum no Dague [cannabis Schedule I federal law — no federal off-duty cannabis employment protection]; DISTINCT from § 12940(a) disability discrimination [no disability required under § 12954] and § 12940(m) reasonable accommodation [no medical purpose required under § 12954]) — generate three billing gaps driven by § 12954 off-duty cannabis use discrimination eligibility and GC-MS/MS test result analysis advisory calls, the concurrent employer HRIS calendar and drug testing laboratory LIMS calendar and CRD complaint investigation calendar advisory calls on external institutional calendars entirely outside attorney control, and the § 12965(b) attorney fee petition and pure Ketchum multiplier advisory calls: § 12954 cannabis discrimination eligibility and GC-MS/MS result analysis advisory calls (7 clients × 2 calls × 42 min × 55% untracked ≈ 5.39 hrs = $1,617–$2,695/year at $300–$500/hr), employer HRIS calendar advisory and drug testing laboratory LIMS calendar advisory and CRD complaint investigation calendar advisory (6 clients × 3 calls × 44 min × 55% ≈ 7.26 hrs = $2,178–$3,630/year), and § 12965(b) attorney fee petition and pure Ketchum multiplier advisory calls (5 clients × 2 calls × 44 min × 55% ≈ 4.03 hrs = $1,210–$2,017/year). For a solo California § 12954 cannabis employment discrimination practice, the annual billing gap from advisory call underlogging is $5,005–$8,342.
TL;DR
ClaimHour captures every § 12954 cannabis discrimination eligibility and GC-MS/MS test result analysis advisory call that starts the § 12965(b) fee documentation period from the DATE OF ADVERSE EMPLOYMENT ACTION BASED ON OFF-DUTY CANNABIS USE OR NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT (simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES: employer's HRIS calendar [Workday/ADP/UKG/SAP SuccessFactors/BambooHR/Paylocity/Ceridian Dayforce — adverse action effective date] + drug testing laboratory's LIMS calendar [Quest Diagnostics/LabCorp/Concentra/Accurate Background/National Health Labs — specimen collection, immunoassay screen, GC-MS/MS confirmation, MRO review, result transmission dates] — all entirely outside plaintiff attorney's scheduling control; FEHA § 12965(b) strong-plaintiff-presumption attorney fees; AB 2188 effective January 1, 2024; pure Ketchum no Dague [cannabis Schedule I, no federal off-duty protection, ADA § 12114(a) excludes current drug users]; DISTINCT from § 12940(a) disability discrimination [§ 12954 requires no disability diagnosis] and § 12940(m) reasonable accommodation [§ 12954 requires no medical purpose]), every concurrent employer HRIS calendar advisory and drug testing lab LIMS calendar advisory and CRD complaint investigation calendar advisory call on external institutional calendars entirely outside the attorney's scheduling control, and every § 12965(b) attorney fee petition and pure Ketchum multiplier advisory call on the post-judgment fee petition calendar — passively, no timer, no audio, no call contents. $29–$59/mo. No PMS required.
§ 12954 cannabis discrimination eligibility and GC-MS/MS test result analysis: calls on two simultaneous institutional calendars
The DATE OF ADVERSE EMPLOYMENT ACTION BASED ON OFF-DUTY CANNABIS USE OR NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT is the primary Welch temporal anchor for § 12954 attorney fee billing documentation. This date is simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES — a unique structure in the fee-petition-mechanics series because the adverse action (in the employer's HRIS) is directly caused by a drug test result (in the laboratory's LIMS) that is itself the basis for the § 12954 violation. The Hensley lodestar starts from this date for five reasons: (1) the employer's HRIS records the adverse action effective date: Workday HCM, ADP Workforce Now, UKG Pro, UKG Ready, SAP SuccessFactors HCM, BambooHR, Paylocity, and Ceridian Dayforce each record the adverse action effective date (hiring rejection, termination effective date, demotion effective date) on the employer's own institutional HRIS and payroll calendar entirely outside plaintiff attorney's scheduling control; the HRIS also records the drug test request date (the date the employer required the drug test in the pre-employment or random drug testing process) and the drug test result receipt date (the date the employer's HR received the result from the laboratory through the employer's HRIS or HR portal); (2) the drug testing laboratory's LIMS records the complete drug test chain-of-custody calendar: Quest Diagnostics Clinical Trials LIMS, LabCorp eScreen LIMS, Concentra occupational health LIMS, Accurate Background drug screening platform, and National Health Laboratories occupational health platform each record the specimen collection date, specimen accession date, immunoassay screening date, GC-MS/MS confirmation date, MRO review date, and electronic result transmission date — all on the laboratory's own institutional LIMS calendar entirely outside plaintiff attorney's scheduling control; (3) the GC-MS/MS confirmation test date is the technically decisive calendar event: the GC-MS/MS (Gas Chromatography-Mass Spectrometry/Mass Spectrometry) confirmatory test result date establishes whether the detected metabolite is non-psychoactive THC-COOH (which triggers § 12954 protection) or active THC (which does not); an employer who bases adverse action on a GC-MS/MS confirmation showing only THC-COOH metabolites is discriminating based on past off-duty cannabis use in violation of § 12954; the GC-MS/MS confirmation date is on the laboratory's own institutional LIMS calendar entirely outside plaintiff attorney's scheduling control; (4) the Medical Review Officer (MRO) review date is on the MRO's institutional calendar: federal DOT testing rules (49 C.F.R. Part 40) and industry best practice require an MRO to review all positive drug test results before reporting them to the employer — the MRO review date is on the MRO's own institutional calendar; if the employer bases adverse action on an initial positive immunoassay screen (before MRO review and GC-MS/MS confirmation), the adverse action may be based on a false positive test result; (5) the result transmission date to the employer is on both the laboratory's LIMS and the employer's HR portal calendar: the electronic transmission of the final drug test result from the laboratory's LIMS to the employer's HR information system or third-party administrator (National Health Laboratories, Verinform, Disa Global Solutions, CRL Health, Sterling) is simultaneously on the laboratory's LIMS transmission log and the employer's HR portal receipt log — both institutional calendars entirely outside plaintiff attorney's scheduling control.
Three initial advisory call types generate untracked billing from the adverse action date: (1) § 12954 cannabis discrimination eligibility and § 12954(b) exemption analysis advisory — arrives when employee retains counsel for cannabis-based adverse action (eligibility analysis: [a] confirm the adverse action was 'based upon' off-duty cannabis use or non-psychoactive cannabis metabolite test result under § 12954(a): establish that the employer's stated reason for the adverse action was the drug test result or knowledge of off-duty cannabis use; [b] confirm the GC-MS/MS confirmation showed non-psychoactive THC-COOH metabolites (not active THC): the key technical question under § 12954 — if the laboratory used a SAMHSA-compliant drug testing protocol, the GC-MS/MS confirmation would distinguish non-psychoactive THC-COOH (past off-duty use) from active THC (recent use/potential impairment); [c] assess the § 12954(b) exemption applicability: confirm the position is not in the building and construction trades, does not require a federal background investigation or security clearance, is not subject to DOT drug testing requirements (commercial motor vehicle drivers, pilots, railroad employees, pipeline workers, transit employees), does not require a commercial driver's license, and the employer is not a federal contractor subject to the Drug-Free Workplace Act; [d] confirm the adverse action was not based on evidence of cannabis impairment at the workplace: § 12954(c)(2) permits employers to discipline employees for cannabis impairment at work — confirm the employer's basis for adverse action was the drug test result alone (off-duty use evidence) and not behavioral observation of workplace impairment; [e] assess concurrent § 12940(a) FEHA disability claim: if the employee uses cannabis for a FEHA-qualifying disability (chronic pain, anxiety, PTSD, cancer), a concurrent § 12940(a) disability discrimination claim may be available with the same § 12965(b) fee framework; 42–48 min per call); (2) GC-MS/MS result chain-of-custody analysis advisory — arrives when laboratory records are needed to establish § 12954 violation (laboratory analysis: [a] request the complete drug test chain-of-custody documentation: the collector's custody and control form (CCF), laboratory accession records, immunoassay screen result with cutoff levels, GC-MS/MS confirmation result with specific metabolite and concentration identified, MRO notes, and result transmission record — all from the laboratory's own LIMS; [b] analyze whether the test detected non-psychoactive THC-COOH metabolites: the § 12954 protection turns on whether the GC-MS/MS confirmation specifically identified non-psychoactive THC-COOH (carboxy-THC), not active THC — if the laboratory report identifies only 'THC' without distinguishing metabolites, request the full mass spectrometry data from the laboratory's LIMS; [c] analyze the immunoassay screening cutoff: the DOT/SAMHSA immunoassay cutoff for marijuana is 50 ng/mL THC metabolites — if the initial immunoassay screen used a lower cutoff (some non-DOT tests use 20 ng/mL), the employer may have used a more aggressive screening standard than required; [d] confirm MRO review occurred before employer notification: if the MRO failed to contact the employee before reporting the positive result to the employer (as required by best practice and DOT rules for DOT-covered positions), the failure is documented in the MRO's institutional calendar; 42–48 min per call); (3) § 12954 vs. ADA/FEHA disability concurrent analysis advisory — arrives before filing (strategic analysis: [a] assess the 'current illegal drug user' exclusion under ADA § 12114(a): cannabis remains Schedule I under federal law — the ADA explicitly excludes 'current' illegal drug users from ADA protection; the term 'current' has been interpreted by courts to mean recent use, not just past use; a GC-MS/MS confirmation showing only non-psychoactive THC-COOH metabolites may indicate only past (not current) use — but the ADA 'current user' exclusion creates genuine uncertainty at case inception; [b] assess concurrent § 12940(a) FEHA disability discrimination: California FEHA protects employees with disabilities including substance use disorder as a qualifying disability; a § 12940(a) disability claim and a § 12954 cannabis discrimination claim can be simultaneously pursued — with the § 12954 claim providing a cleaner factual pathway that avoids the 'current user' debate; [c] assess pure Ketchum no Dague: confirm that no federal law protects off-duty cannabis employment — cannabis Schedule I classification means no federal employment law creates a Dague constraint on the § 12965(b) fee petition; [d] assess the AB 2188 effective date: § 12954 is effective January 1, 2024 — adverse actions based on drug test results before January 1, 2024 are not covered; 42–48 min per call). At 55% untracked: 7 clients × 2 calls × 42 min × 55% = 323.4 min / 60 = 5.39 hours = $1,617–$2,695/year at $300–$500/hr.
Employer HRIS calendar and drug testing laboratory LIMS calendar and CRD complaint investigation calendar: calls on three institutional calendars entirely outside attorney control
A California Gov. Code § 12954 cannabis employment discrimination case involves three concurrent external institutional calendars that run entirely outside the plaintiff attorney's scheduling control: the employer's own HRIS and payroll system calendar [Workday HCM, ADP Workforce Now, UKG Pro, UKG Ready, SAP SuccessFactors HCM, BambooHR, Paylocity, and Ceridian Dayforce each record: (a) the drug test request date (the date the employer required the drug test in the pre-employment screening, random drug testing, or post-incident testing process — on the employer's own HRIS calendar); (b) the drug test result receipt date (the date the employer's HR received the final drug test result from the laboratory through the employer's HRIS or HR portal, Disa Global Solutions, CRL Health, or Verinform third-party administrator — on the employer's own HRIS calendar); (c) the adverse action decision date (the date the employer's HR manager or management team made the decision to reject the applicant, terminate, or demote the employee based on the drug test result — on the employer's own HR correspondence and HRIS calendar); (d) the adverse action effective date (the hiring rejection letter date, the termination effective date, or the demotion effective date — on the employer's own HRIS and payroll calendar); (e) the final paycheck date (if the adverse action was termination, the final paycheck date under Lab. Code § 201 — on the employer's own payroll calendar)]; the drug testing laboratory's own Laboratory Information Management System (LIMS) calendar [Quest Diagnostics Clinical Trials LIMS (the largest US occupational drug testing laboratory), LabCorp eScreen LIMS (second largest US occupational drug testing laboratory), Concentra occupational health LIMS (largest US occupational health clinic network), Accurate Background drug screening platform, and National Health Laboratories occupational health platform each record: (a) the specimen collection date (the date and time the collection site (urgent care clinic, Quest PSC, LabCorp PSC, Concentra clinic, or third-party collection site) collected the urine, hair, or oral fluid specimen — on the collection site's institutional calendar and the laboratory's LIMS); (b) the specimen accession date (the date the central testing laboratory received and entered the specimen into the LIMS — on the laboratory's institutional LIMS calendar); (c) the immunoassay screening date (the date the laboratory ran the initial ELISA or EMIT immunoassay screen — on the laboratory's LIMS calendar; the immunoassay screens for THC metabolites at a detection cutoff of 50 ng/mL for DOT-compliant tests; at 20 ng/mL for some non-DOT tests); (d) the GC-MS/MS confirmation date (the date the laboratory ran the Gas Chromatography-Mass Spectrometry/Mass Spectrometry confirmatory test — on the laboratory's LIMS calendar; this test specifically identifies the compound as THC-COOH [carboxy-THC, non-psychoactive] or THC [psychoactive]; the GC-MS/MS result date is the technically decisive date for § 12954 analysis); (e) the Medical Review Officer review and verification date (the date the MRO reviewed the positive GC-MS/MS confirmation, contacted the employee to determine if there was a legitimate medical explanation, and verified the result as a confirmed positive — on the MRO's own institutional calendar); (f) the electronic result transmission date (the date the laboratory's LIMS transmitted the final verified result to the employer's HR portal, Disa Global Solutions, CRL Health, Verinform, or Sterling third-party administrator — on the laboratory's LIMS transmission log)]; and the California Civil Rights Department (CRD) complaint investigation calendar [CRD complaint intake date, Right-to-Sue notice issuance date (1-year civil action deadline under § 12965(f)(1) starts from issuance), CRD mediation scheduling date, investigation assignment date, investigation completion date — all on CRD's own institutional calendar entirely outside plaintiff attorney's scheduling control]. Ketchum v. Moses 24 Cal.4th 1122 (2001). PLCM Group 22 Cal.4th 1084 (2000). Hensley v. Eckerhart 461 U.S. 424 (1983). Missouri v. Jenkins 491 U.S. 274 (1989) fees-on-fees.
Three concurrent external institutional calendar advisory call types generate untracked billing: (1) employer HRIS calendar monitoring advisory — arrives when HRIS records establish the adverse action timeline (HRIS calendar analysis: [a] request the employer's drug test policy records: the employer's written drug-free workplace policy (if any), the specific drug testing protocol (pre-employment, random, post-incident), and the date the drug testing policy was communicated to the applicant or employee — all on the employer's own HRIS and HR document management calendar; [b] request the drug test request date and drug test result receipt date from the employer's HRIS: establishing the time between drug test result receipt and adverse action decision (if the adverse action was immediate upon receipt of the result, without independent assessment of whether the metabolites were non-psychoactive, this supports the § 12954 violation finding); [c] confirm the adverse action effective date vs. the termination notice date: if the employer gave notice of termination on a date earlier than the adverse action effective date, the termination notice date may be the primary Welch anchor; [d] confirm the final paycheck date: Lab. Code § 201 requires immediate payment of final wages on the termination date — if the employer failed to pay final wages immediately, a concurrent wage claim may be available; 44–50 min per call); (2) drug testing laboratory LIMS calendar monitoring advisory — arrives when laboratory records are needed to establish the GC-MS/MS non-psychoactive metabolite finding (LIMS calendar analysis: [a] request the complete chain-of-custody documentation from the laboratory's LIMS: the CCF, accession records, immunoassay screen result, GC-MS/MS confirmation result with specific metabolite identification (THC-COOH vs. THC), MRO notes, and transmission log; [b] confirm the GC-MS/MS confirmation date: the date the GC-MS/MS confirmation identified non-psychoactive THC-COOH metabolites is on the laboratory's institutional LIMS calendar — this date is the technically decisive date establishing the § 12954 violation basis; [c] analyze whether the laboratory used SAMHSA guidelines: SAMHSA-certified laboratories follow 49 C.F.R. Part 40 protocols, which specify the GC-MS/MS confirmatory cutoff of 15 ng/mL for THC-COOH — if the laboratory is not SAMHSA-certified or used a different confirmatory cutoff, the reliability of the non-psychoactive finding requires analysis; [d] request MRO documentation: the MRO's notes documenting the employee contact attempt, the employee's explanation for the positive result, and the MRO's verification decision are on the MRO's institutional calendar — MRO failure to contact the employee before reporting a positive result (as required by best practice) may establish additional violations; 44–50 min per call); (3) CRD complaint investigation calendar monitoring advisory — arrives when CRD administrative calendar controls the civil action timeline (CRD calendar analysis: [a] monitor the Right-to-Sue notice issuance date: the 1-year civil action filing deadline under § 12965(f)(1) starts from the CRD Right-to-Sue notice issuance date — on CRD's institutional calendar; [b] assess EEOC concurrent charge: if the cannabis discrimination claim also involves a disability discrimination component (§ 12940(a) FEHA claim based on substance use disorder as a qualifying disability), dual-filing with the EEOC may be required — the EEOC charge receipt date is on the EEOC's institutional calendar; [c] assess the AB 2188 effective date for the claim: confirm the adverse action occurred on or after January 1, 2024 — § 12954 does not apply to adverse actions before the effective date; [d] monitor CRD mediation scheduling: CRD's dispute resolution division may schedule a mediation — the mediation date on CRD's institutional calendar determines when the mediation preparation generates advisory calls; 44–50 min per call). At 55% untracked: 6 clients × 3 calls × 44 min × 55% = 435.6 min / 60 = 7.26 hours = $2,178–$3,630/year at $300–$500/hr.
§ 12965(b) attorney fee petition and pure Ketchum multiplier: calls on the post-judgment fee petition calendar
Fee recovery for § 12954 cannabis employment discrimination is through Gov. Code § 12965(b) FEHA strong-plaintiff-presumption framework. The § 12965(b) fee petition requires a Hensley lodestar from the DATE OF ADVERSE EMPLOYMENT ACTION BASED ON NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT through § 12954 eligibility analysis, GC-MS/MS result chain-of-custody documentation, § 12954(b) exemption analysis, employer HRIS calendar monitoring, drug testing laboratory LIMS calendar monitoring, CRD complaint administrative processing, litigation, and fee petition. Cannabis remains Schedule I under the Controlled Substances Act (21 U.S.C. § 812) — no federal law protects off-duty cannabis employment, and the ADA explicitly excludes current illegal drug users under 42 U.S.C. § 12114(a) — therefore the § 12965(b) fee petition for § 12954 cannabis discrimination is pure Ketchum no Dague: no federal analog creates a Ketchum/Dague split constraint. Ketchum v. Moses 24 Cal.4th 1122 (2001). PLCM Group 22 Cal.4th 1084 (2000). Hensley 461 U.S. 424 (1983). Missouri v. Jenkins 491 U.S. 274 (1989) fees-on-fees.
Two § 12965(b) post-judgment advisory call types generate untracked billing: (1) § 12954 damages and § 12965(b) pure Ketchum fee petition component assembly advisory — arrives at judgment (damages and fee components: [a] lost wages: back pay from the adverse action date through judgment — the employer HRIS payroll records establish the pre-adverse-action wage rate; for rejected applicants, the lost wages calculation begins from the date employment would have started; [b] front pay: future wage losses if reinstatement is impractical; [c] emotional distress damages: cannabis employment discrimination based on a workplace drug test result is often devastating — the employee or applicant reasonably believes they passed the drug test (because non-psychoactive metabolites reflect only past off-duty use, not impairment), and the adverse action appears arbitrary; [d] punitive damages: if the employer's cannabis discrimination was malicious, oppressive, or fraudulent under Civ. Code § 3294 (for example, if the employer knew about § 12954 and violated it deliberately), punitive damages are available; [e] § 12965(b) fee petition: the lodestar from the adverse action date through all § 12954/FEHA work and fee petition, with pure Ketchum multiplier analysis; [f] Missouri v. Jenkins fees-on-fees: attorney fees for preparing the § 12965(b) fee petition are themselves recoverable; 44–50 min per call); (2) pure Ketchum multiplier analysis advisory — arrives at fee petition (Ketchum five-factor multiplier analysis for § 12954 pure Ketchum no Dague fee petition: (i) GC-MS/MS non-psychoactive metabolite distinction uncertainty at inception: at case inception, whether the laboratory's LIMS records would show non-psychoactive THC-COOH metabolites (§ 12954 protection) vs. active THC (no protection) was not determinable without laboratory LIMS discovery — the technical outcome of the GC-MS/MS result was genuinely uncertain at case inception; (ii) § 12954(b) exemption applicability uncertainty: at case inception, whether the position would fall within a § 12954(b) exemption (federal contractor, DOT-regulated, security clearance required) was not determinable without full discovery of the employer's government contractor status, the specific DOT regulations applicable to the position, and the background investigation requirements; (iii) 'current user' ADA exclusion uncertainty: at case inception, whether the ADA 'current illegal drug user' exclusion under § 12114(a) would be raised as a defense — creating a contested issue about the timing between the drug test and the adverse action — was not determinable; (iv) MRO review protocol uncertainty: at case inception, whether the laboratory and MRO followed the correct SAMHSA protocol for distinguishing non-psychoactive metabolites was not determinable without laboratory LIMS and MRO record discovery; (v) effective date applicability uncertainty: at case inception, whether the adverse action date fell on or after January 1, 2024 (the AB 2188 effective date) was not always determinable when the adverse action straddled the effective date or when the drug test was administered before the effective date but the adverse action occurred after; 44–50 min per call). At 55% untracked: 5 clients × 2 calls × 44 min × 55% = 242 min / 60 = 4.03 hours = $1,210–$2,017/year at $300–$500/hr.
How ClaimHour fits California § 12954 cannabis employment discrimination practice
California cannabis employment discrimination Gov. Code § 12954 solos billing hourly on FEHA attorney fee recovery — with § 12954 cannabis discrimination eligibility and GC-MS/MS test result analysis advisory calls arriving when employee or applicant retains counsel for cannabis-based adverse action (DATE OF ADVERSE EMPLOYMENT ACTION BASED ON OFF-DUTY CANNABIS USE OR NON-PSYCHOACTIVE CANNABIS METABOLITE DRUG TEST RESULT = primary Welch anchor; simultaneously in TWO DISTINCT EXTERNAL INSTITUTIONAL CALENDAR DATES: employer's HRIS calendar [Workday/ADP/UKG/SAP SuccessFactors/BambooHR/Paylocity/Ceridian Dayforce — adverse action effective date] + drug testing laboratory's LIMS calendar [Quest Diagnostics/LabCorp/Concentra/Accurate Background/National Health Labs — specimen collection, immunoassay screen, GC-MS/MS confirmation, MRO review, result transmission dates] — ONLY page in fee-petition-mechanics series where primary Welch anchor is simultaneously in EMPLOYER HRIS AND DRUG TESTING LABORATORY LIMS; FEHA § 12965(b) strong-plaintiff-presumption attorney fees; AB 2188 effective January 1, 2024; pure Ketchum no Dague [cannabis Schedule I, no federal off-duty protection]; DISTINCT from § 12940(a) disability discrimination [§ 12954 requires no disability diagnosis] and § 12940(m) reasonable accommodation [§ 12954 requires no medical purpose or physician recommendation]), employer HRIS calendar monitoring advisory calls on the employer's own institutional HRIS calendar entirely outside plaintiff attorney's scheduling control, drug testing laboratory LIMS calendar monitoring advisory calls on the laboratory's own institutional LIMS calendar entirely outside plaintiff attorney's scheduling control, CRD complaint investigation calendar monitoring advisory calls on CRD's own institutional calendar entirely outside plaintiff attorney's scheduling control, and § 12965(b) attorney fee petition and pure Ketchum multiplier advisory calls arriving at judgment — and if your § 12965(b) FEHA lodestar documentation must satisfy the Hensley contemporaneous-record standard with pure Ketchum multiplier analysis from the DATE OF ADVERSE EMPLOYMENT ACTION through GC-MS/MS chain-of-custody analysis, § 12954(b) exemption analysis, LIMS and HRIS discovery, CRD administrative processing, litigation, and fee petition, ClaimHour was built for that gap.